Abstract
Background/Aims: Although prolonged hypoxemia (henceforth referred to as hypoxemia) is not uncommon during moderate sedation for endoscopy, there are only sparse data regarding its relationship with medications, endoscopic intubations and ventilation patterns. We aimed to study these relationships. Methods: 123 patients enrolled in the control arm of a randomized trial of ventilation monitoring during endoscopy were analyzed. Hypoxemia was defined as oxygen saturation of <90% for ≧15 s, and apnea as lack of respiratory activity for ≧15 s. Results: There were 132 hypoxemic events; 46 (35%) and 112 (85%) events occurred within 1 and 5 min of medication administration/endoscopic intubations, and conversely, 46/638 (7%) and 112/638 (18%) of all medication administration/endoscopic intubations led to hypoxemia in 1 and 5 min, respectively. Apnea, abnormal ventilation and normal ventilation were associated with 36, 30 and 34% of all hypoxemia events, respectively. However, only 101/268 (38%) apnea/abnormal ventilation events led to hypoxemia. Significant predictors of apnea were total dose of meperidine/fentanyl 1.3 (1.02–1.6) and total dose of midazolam 0.84 (0.71–0.99). Conclusions: Hypoxemia occurs typically within 5 min of medication administration or endoscope intubation and only one third of all apnea/abnormal ventilation events eventually lead to hypoxemia.
Journal Section:
Original Paper
References
1.
Seeff LC, Richards TB, Shapiro JA, et al: How many endoscopies are performed for colorectal cancer screening? Results from CDC’s survey of endoscopic capacity. Gastroenterology 2004;127:1670–1677.
[PubMed]
2.
Sharma VK, Nguyen CC, Crowell MD, et al: A national study of cardiopulmonary unplanned events after GI endoscopy. Gastrointest Endosc 2007;66:27–34.
[PubMed]
3.
American Society for Gastrointestinal Endoscopy. Standards of Practice Committee. Sedation and anesthesia in GI endoscopy. Gastrointest Endosc 2008;68:205–216.
[PubMed]
4.
Kohn LT, Corrigan JM, Donaldson MS: To Err Is Human, Building a Safer Health System. Committee on Quality of Health Care in America, Institute of Medicine. Washington, National Academy Press, 1999.
5.
Griffin MS, Chung SCS, Leung JWC, et al: Effects of oxygen and hypoxemia and tachycardia during endoscopic retrograde cholangiopancreatography. BMJ 1990;300:83–84.
[PubMed]
6.
Woods SDS, Chung SCS, Leung JWC, et al: Hypoxia and tachycardia during endoscopic retrograde cholangiopancreatography: detection by pulse oximetry. Gastrointest Endosc 1989;35:523–525.
[PubMed]
7.
Jurell KR, O’Connor KW, Slack J, et al: Effect of supplemental oxygen on cardiopulmonary changes during gastrointestinal endoscopy. Gastrointest Endosc 1994;40:665–670.
[PubMed]
8.
Johnston SD, McKenna A, Tham TC: Silent myocardial ischaemia during endoscopic retrograde cholangiopancreatography. Endoscopy 2003;35:1039–1042.
[PubMed]
9.
Fisher L, Fisher A, Thomson A: Cardiopulmonary complications of ERCP in older patients. Gastrointest Endosc 2006;63:948–955.
[PubMed]
10.
Holm C, Christensen M, Rasmussen V, et al: Hypoxaemia and myocardial ischaemia during colonoscopy. Scand J Gastroenterol 1998;33:769–772.
[PubMed]
11.
Coté CJ, Notterman DA, Karl HW, et al: Adverse sedation events in pediatrics: a critical incident analysis of contributing factors. Pediatrics 2000;105:805–814.
[PubMed]
12.
Rimmer KP, Graham K, Whitelaw WA, et al: Mechanisms of hypoxemia during panendoscopy. J Clin Gastroenterol 1989;11:17–22.
[PubMed]
13.
Lipper B, Simon D, Cerrone F: Pulmonary aspiration during emergency endoscopy in patients with upper gastrointestinal hemorrhage. Crit Care Med 1991;19:330–333.
[PubMed]
14.
Qadeer MA, Vargo JJ, Dumot JA, et al: Capnographic monitoring of respiratory activity improves safety of sedation for endoscopic cholangiopancreatography and ultrasonography. Gastroenterology 2009;136:1568–1576.
[PubMed]
15.
Freeman ML, Hennessy JT, Cass OW, et al: Carbon dioxide retention and oxygen retention during gastrointestinal endoscopy. Gastroenterology 1993;105:331–339.
[PubMed]
16.
Cohen LB, Holub J, Lieberman DA, et al: Does routine use of supplemental oxygen during endoscopy really reduce the risk of cardiopulmonary complications? Gastrointest Endosc 2007;65:AB103.
17.
Zuccaro G, Radaelli F, Vargo J, et al: Routine use of supplemental oxygen prevents recognition of prolonged apnea during endoscopy. Gastrointest Endosc 2000;51:AB141.
18.
Rozen P, Fireman Z, Gilat T: Arterial oxygen tension changes in elderly patients undergoing upper gastrointestinal endoscopy. II. Influence of the narcotic premedication and endoscope diameter. Scand J Gastroenterol 1981;16:299–303.
[PubMed]
19.
Ferreira LE, Baron TH: Comparison of safety and efficacy of ERCP performed with the patient in supine and prone positions. Gastrointest Endosc 2008;67:1037–1043.
[PubMed]
20.
Papachristou GI, Gleeson FC, Papachristou DJ, et al: Endoscopist administered sedation during ERCP: impact of chronic narcotic/benzodiazepine use and predictive risk of reversal agent utilization. Am J Gastroenterol 2007;102:738–743.
[PubMed]
21.
Barkin JS, Krieger B, Blinder M, et al: Oxygen desaturation and changes in breathing pattern in patients undergoing colonoscopy and gastroscopy. Gastrointest Endosc 1989;35:526–530.
[PubMed]
22.
De Sousa AG, Cercato C, Mancini MC, et al: Obesity and obstructive sleep apnea-hypopnea syndrome. Obes Rev 2008;9:340–354.
[PubMed]
23.
Qadeer MA, Vargo JJ, Patel S, et al: Utility of bispectral index monitoring of moderate sedation with the combination of meperidine and midazolam during gastrointestinal endoscopy. Clin Gastroenterol Hepatol 2008;6:102–108.
[PubMed]
© 2011 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2011
You do not currently have access to this content.
